Fungal infections of the lung

Abstract

Fungi, both endemic and opportunistic, continue to be recognized as increasingly frequent pulmonary pathogens. Better appreciation of their epidemiology and clinical course, as well as clarification of the roles of the newer triazoles and lipid formulations of amphotericin B in treatment, have occurred within the past few years. Both endemic and opportunistic fungal pulmonary pathogens are reviewed, with emphasis on recent therapeutic advances.

Invasive Pulmonary Aspergillosis in an Immunocompetent Patient: An Atypical Presentation

“…Imaging played a crucial role in our patient's diagnosis, with chest radiography revealing a rounded opacity in the right upper zone and HRCT demonstrating a consolidative lesion with surrounding ground-glass opacity, indicative of the "halo sign." These findings are consistent with previous reports of IPA in immunocompetent patients [ 7 , 8 ]. Laboratory investigations, including sputum examination and blood tests, were inconclusive initially.…”

Synthesis, Characterization, and Anticancer Activities of Pyrogallol‐Based Arylspiroborates

“…Although boric acid and borax have been known for centuries as insecticides, especially for ant infestations, researchers are now looking at simple boron-containing compounds for their potential pharmaceutical and medicinal properties [1][2][3][4][5][6][7][8][9][10][11]. Indeed, Duggan and co-workers have been investigating the use of arylspiroborate ester salts for their potential wood protection properties [12][13][14][15].…”